David Hodges in Spring, Texas

Home Texas Spring

David Hodges has Hematology/oncology as his primary medical specialty. Their primary office is: 11 Kingscote Way in Spring, Texas. There are 2 additional office locations for David Hodges that can be viewed towards the end of their profile.

They're a part of the: Allen Memorial Hospital Corporation medical group which has around 98 members. You can call their office at 319-233-2701 to schedule an appointment. , license information, procedures and more. They attended Sorry, his university is not listed and graduated in 2009 (around 15 years of experience). They are listed as doing telehealth appointments.

David Blake Hodges Office Phone and Directions

David Hodges
Allen Memorial Hospital Corporation
11 Kingscote Way
Spring, Texas 77382
319-233-2701

Patient Ratings
Please rate your experience with David Hodges below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 319-233-2701

Enter a starting address:

Healthcare Info for David Hodges

Medical School: Sorry, his university is not listed
Graduation Year: 2009
The Primary Medical Specialty for David Hodges is listed as: Hematology/oncology
Approximate Years of Experience: 15
PAC (PECOS ID)#: 2961710926
NPI #: 1619101896
NPI Created On: 05/04/2009
NPI Last Updated Listed as: 01/12/2018
Primary Taxonomy Code: 207R00000X
License Number:
BP10034606
Listed Gender: Male

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

Humana
Community Health Choice
Celtic Insurance Company
Blue Cross Blue Shield

They are listed as accepting new patients.

Languages spoken by staff include: English, American Sign, Creoles and Pidgins, Danish, Chinese, Czech.

Services and Procedures include:

Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour
New patient office or other outpatient visit, typically 45 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient, visit typically 25 minutes
Initial hospital inpatient care, typically 50 minutes per day
Subsequent hospital inpatient care, typically 25 minutes per day
Physician telephone patient service, 5-10 minutes of medical discussion
Physician telephone patient service, 11-20 minutes of medical discussion

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788483903

Being Disputed:: No

Product Related: No

Payments Total: $99

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788483905

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Payments Total: $6

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788483909

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: DARZALEX

Associated Drug #2: 57894-502-05

Payments Total: $23

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788483907

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09

Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788483911

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: BALVERSA

Associated Drug #2: 59676-030-56

Payments Total: $25

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788483913

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09

Payments Total: $1

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788483915

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09

Payments Total: $1

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788483917

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09

Payments Total: $24

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788483919

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09

Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788483921

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09

Additional Office Locations

1. Allen Memorial Hospital Corporation
3530 W 4th St
Waterloo, IA 50701
Uph Waterloo Community Cancer
Group Members: 98

Phone: 319-233-2701

Enter a starting address:

2. Allen Memorial Hospital Corporation
1825 Logan Ave
Waterloo, IA 50703
Group Members: 98

Enter a starting address:

Hematology/oncology Professionals in Spring

1.
Jonathan Lu

2255 E Mossy Oaks Rd
Spring, TX
David P Ellent Pllc

2.
David Ellent MD

2255 E Mossy Oaks Rd
Spring, TX
David P Ellent Pllc

Providers in Allen Memorial Hospital Corporation

1.Abdullah Alwahdani Md

1825 Logan Ave
Waterloo Ia 50703-1916
Allen Memorial Hospital Corporation
Interventional Cardiology

2.Paula Anderson Np

1825 Logan Ave
Waterloo Ia 50703-1916
Allen Memorial Hospital Corporation
Nurse Practitioner

3.Eric Andresen

1717 W Ridgeway Ave
Waterloo Ia 50701-4543
Allen Memorial Hospital Corporation
Urology

4.Eric Andresen

1825 Logan Ave
Waterloo Ia 50703-1916
Allen Memorial Hospital Corporation
Urology

5.Rajeev Anugu

1825 Logan Ave
Waterloo Ia 50703-1916
Allen Memorial Hospital Corporation
Diagnostic Radiology

6.Eric Askeland

1717 W Ridgeway Ave
Waterloo Ia 50701-4543
Allen Memorial Hospital Corporation
Urology

View all 98 members of Allen Memorial Hospital Corporation medical group